- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05662930
Evaluation Of Stress Response In Diabetic Hypertensive Patients
Diyabetik Hipertansif Hastalarda Stres Yanıtının Değerlendirilmesi
In this research, we aimed to examine salivary cortisol changes in the cognitive stress response of patients with Hypertension + Diabetes Mellitus (HT+DM) and Hypertension (HT) and to determine the differences between them.
The research was conducted by solving an arithmetic task as a stress test in 62 patients with HT+DM and HT that are being treated in the outpatient clinic of Medical Pharmacology and Clinical Pharmacology Department at Istanbul University, Istanbul Medical Faculty Hospital.
Study Overview
Status
Conditions
Detailed Description
In this study, saliva samples were taken for cortisol measurement, and patients were instructed to place the cotton piece in the salivette® tubes directly into their mouths without touching it with anything, hold it for 30-60 seconds, and then insert it back into the tubes in the same way, four times total, once before arithmetic stress and three times after stress, on Tuesdays, Wednesdays, and Thursdays between the hours of 12:00-16:00.
Salivary cortisol was measured using the electro-chemiluminescence immunoassay.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey, 34000
- Istanbul University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Using antihypertensive treatment for the last 3 months
- Diagnosed with Type 2 Diabetes Mellitus and taking medication for at least 3 months
- Being between the ages of 40-65
- Being male
- Having signed the informed consent form
Exclusion Criteria:
- Female gender
- Patients younger than 40 years old or older than 65 years old
- Uncontrolled blood pressure (SBP>140 mmHg, DBP>90 mmHg)
- Using antipsychotic medication
- Using current treatment for less than 3 months
- Having a previous MI
- Having a previous stroke
- Having a lung disease
- Having organ failure
- Having Cushing's disease
- Having aldosteronism
- Failure to sign the informed consent form
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hypertension + Diabetes Mellitus (HT+DM)
Patients who fulfilled the following criteria were included in this group:
|
In a quiet environment, a white paper in A4 format was placed in front of the patient on the table, and the patients were asked to subtract the number 3 from 2907 for 100 seconds. The researcher was standing in front of the patient and asks to make corrections by giving a warning whenever the patient made a mistake in the calculation. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the first subtraction process, patients were asked to subtract 7 from 6828 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 13 from 9561 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 8 from 5113 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 14 from 8318 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 17 from 9994 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. |
|
Hypertension (HT)
Patients who fulfilled the following criteria were included in this group:
|
In a quiet environment, a white paper in A4 format was placed in front of the patient on the table, and the patients were asked to subtract the number 3 from 2907 for 100 seconds. The researcher was standing in front of the patient and asks to make corrections by giving a warning whenever the patient made a mistake in the calculation. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the first subtraction process, patients were asked to subtract 7 from 6828 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 13 from 9561 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 8 from 5113 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 14 from 8318 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. In the same A4-sized white paper that was placed in front of each patient on a table, immediately after the previous subtraction process, patients were asked to subtract 17 from 9994 for another 100 seconds. When the patient made a calculating error, the researcher stood in front of the patient and asked them to make corrections by issuing a warning. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cortisol
Time Frame: Baseline
|
A saliva sample is collected for cortisol evaluation
|
Baseline
|
|
Cortisol
Time Frame: 30 minutes after beginning
|
A saliva sample is collected
|
30 minutes after beginning
|
|
Cortisol
Time Frame: 45 minutes after beginning
|
A saliva sample is collected
|
45 minutes after beginning
|
|
Cortisol
Time Frame: 60 minutes after beginning
|
A saliva sample is collected
|
60 minutes after beginning
|
|
Blood pressure
Time Frame: Baseline
|
The patient is rested by sitting before the measurement
|
Baseline
|
|
Blood pressure
Time Frame: 15 minutes after beginning measurement
|
The patient is rested by sitting before the measurement
|
15 minutes after beginning measurement
|
|
Blood pressure
Time Frame: 35 minutes after beginning measurement
|
The patient is rested by sitting before the measurement
|
35 minutes after beginning measurement
|
|
Blood pressure
Time Frame: 50 minutes after beginning measurement
|
The patient is rested by sitting before the measurement
|
50 minutes after beginning measurement
|
|
Blood pressure
Time Frame: 75 minutes after beginning measurement
|
The patient is rested by sitting before the measurement
|
75 minutes after beginning measurement
|
|
Aldosterone
Time Frame: Baseline
|
Venous blood sample is collected
|
Baseline
|
|
Heart Rate
Time Frame: Beginning
|
The patient is rested by sitting before the measurement
|
Beginning
|
|
Heart Rate
Time Frame: 15 minutes after beginning
|
The patient is rested by sitting before the measurement
|
15 minutes after beginning
|
|
Heart Rate
Time Frame: 35 minutes after beginning
|
The patient is rested by sitting before the measurement
|
35 minutes after beginning
|
|
Heart Rate
Time Frame: 50 minutes after beginning
|
The patient is rested by sitting before the measurement
|
50 minutes after beginning
|
|
Heart Rate
Time Frame: 75 minutes after beginning
|
The patient is rested by sitting before the measurement
|
75 minutes after beginning
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental state examination
Time Frame: Baseline
|
Mini Mental State Examination - MMSE is used to evaluate the mental state
|
Baseline
|
|
Physical activity
Time Frame: Baseline
|
International Physical Activity Questionnaire is used to evaluate the level of physical activity
|
Baseline
|
|
Health related Quality of life
Time Frame: Baseline
|
SF-36 v2 is used to evaluate the health related quality of life
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Iliriana Alloqi Tahirbegolli, Prof.Ass.Dr., Istanbul University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22939
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on First arithmetic problem solving
-
Hospices Civils de LyonUniversity of LausanneCompleted
-
University of WashingtonNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
University of OttawaOttawa Hospital Research InstituteActive, not recruiting
-
Washington University School of MedicineNurses for Newborns FoundationCompletedPost-partum DepressionUnited States
-
VA Office of Research and DevelopmentCompletedDepression | AnxietyUnited States
-
University of PittsburghNational Institute of Mental Health (NIMH)CompletedMild Cognitive ImpairmentUnited States
-
VA Office of Research and DevelopmentCompleted
-
University of SheffieldUniversity of ManchesterCompleted
-
Children's Hospital Medical Center, CincinnatiPatient-Centered Outcomes Research Institute; Children's Hospital Colorado; Nationwide... and other collaboratorsCompletedWounds and Injuries | Brain Injuries | Craniocerebral Trauma | Trauma, Nervous System | Brain Concussion | Head Injuries, Closed | Head Injury | Brain Edema | Disorders of Environmental Origin | Brain Hemorrhage, Traumatic | Subdural Hematoma | Epidural Hematoma | Intracranial Edema | Tbi | Cortical ContusionUnited States
-
University of California, San FranciscoSan Francisco Veterans Affairs Medical CenterCompletedMajor Depressive DisorderUnited States